CVS Health

Forecast & Rating27 analysts currently cover CVS Health, with about 92.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $115.48, about 23.5% upside from the current price of $93.47. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 42.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study CVS Health closely still see room for the stock to rise. Data as of Oct 12, 2026; for reference only and not investment advice.